Empagliflozin (Jardiance)

off-label Rx · medium oversightFDA-approved

SGLT2 inhibition; cardio-renal protection

Summary

SGLT2 inhibitor; renal glucose excretion with cardiometabolic and emerging longevity interest.

How it works

SGLT2 inhibition → glucosuria
Cardio-renal protection

Dosing

unit: mg
frequency: daily
high dose: 25
standard dose: 10
administration route: Oral

Cycling

Continuous

Side effects

common: ["Genital mycotic infections","Volume depletion"]

warnings: ["Rare euglycemic DKA"]

Verified citations

2 · PubMed-checked

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.clinicalPMID 27299675 ↗
Empagliflozin in the treatment of heart failure.reviewPMID 38865086 ↗

Used for

Legal / compounding

FDA-approved

Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.